Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.79
+0.14505.49%
Volume:2.96M
Turnover:8.18M
Market Cap:438.76M
PE:5.74
High:2.88
Open:2.66
Low:2.65
Close:2.64
Loading ...

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Zacks
·
03 Jan

Neumora Stock Hits Record Low on Depression Drug Study Failure

Zacks
·
03 Jan

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?

Zacks
·
03 Jan

VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag

Zacks
·
02 Jan

CytomX heading into ‘major catalyst year,’ says JonesResearch

TIPRANKS
·
30 Dec 2024

JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723

Zacks
·
27 Dec 2024

Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek

Zacks
·
24 Dec 2024

AZN's Tagrisso Gets Approval in the EU for Expanded Use in NSCLC

Zacks
·
23 Dec 2024

VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo

Zacks
·
21 Dec 2024

KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707

Zacks
·
20 Dec 2024

SRPT Finishes Enrolment in Late-Stage Study for Rare Muscular Disorder

Zacks
·
19 Dec 2024

GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer

Zacks
·
18 Dec 2024

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

Zacks
·
17 Dec 2024

Merck Ends Development of Two Experimental Cancer Drugs

Zacks
·
17 Dec 2024

CHMP Endorses Merck's Kidney Cancer Drug for Two Indications

Zacks
·
16 Dec 2024

EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce

Zacks
·
16 Dec 2024

CytomX Therapeutics (CTMX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks
·
16 Dec 2024

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline

Zacks
·
16 Dec 2024

KRYS Stock Down on Initial Clinical Updates on KB407 & KB408

Zacks
·
14 Dec 2024

SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS

Zacks
·
13 Dec 2024